Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4,288.00 JPY | -0.19% |
|
+0.52% | +5.28% |
Fiscal Period: March | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 275B | 252B | 270B | 292B | 311B | |||||
Total Revenues | 275B | 252B | 270B | 292B | 311B | |||||
Cost of Goods Sold, Total | 218B | 200B | 210B | 226B | 239B | |||||
Gross Profit | 56.6B | 51.95B | 60.32B | 65.94B | 71.84B | |||||
Selling General & Admin Expenses, Total | 27.6B | 26.81B | 29.93B | 30.56B | 33.98B | |||||
Provision for Bad Debts | 2M | - | 95M | - | - | |||||
R&D Expenses | - | - | - | 2.32B | 2.4B | |||||
Depreciation & Amortization - (IS) | 140M | 126M | 131M | 131M | 246M | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 465M | 465M | 465M | - | - | |||||
Other Operating Expenses | - | - | - | -208M | -104M | |||||
Other Operating Expenses, Total | 28.21B | 27.4B | 30.62B | 32.8B | 36.53B | |||||
Operating Income | 28.39B | 24.55B | 29.7B | 33.14B | 35.31B | |||||
Interest Expense, Total | -9M | -7M | -42M | -101M | -92M | |||||
Interest And Investment Income | 577M | 516M | 1B | 529M | 545M | |||||
Net Interest Expenses | 568M | 509M | 960M | 428M | 453M | |||||
Income (Loss) On Equity Invest. | 41M | -53M | 39M | 18M | 31M | |||||
Currency Exchange Gains (Loss) | -39M | -48M | -120M | -118M | -31M | |||||
Other Non Operating Income (Expenses) | -654M | 193M | 262M | 26M | 87M | |||||
EBT, Excl. Unusual Items | 28.3B | 25.15B | 30.84B | 33.49B | 35.85B | |||||
Restructuring Charges | - | - | - | -115M | -142M | |||||
Gain (Loss) On Sale Of Investments | 2.39B | 2.03B | - | - | 144M | |||||
Gain (Loss) On Sale Of Assets | -31M | -50M | -29M | -125M | -241M | |||||
Asset Writedown | - | - | - | -1.15B | -177M | |||||
Legal Settlements | - | - | -702M | - | - | |||||
Other Unusual Items | -2B | -1.82B | - | - | - | |||||
EBT, Incl. Unusual Items | 28.66B | 25.32B | 30.11B | 32.1B | 35.44B | |||||
Income Tax Expense | 9.39B | 7.71B | 9.5B | 9.38B | 10.28B | |||||
Earnings From Continuing Operations | 19.28B | 17.6B | 20.61B | 22.72B | 25.16B | |||||
Net Income to Company | 19.28B | 17.6B | 20.61B | 22.72B | 25.16B | |||||
Minority Interest | -725M | -622M | -636M | -715M | -915M | |||||
Net Income - (IS) | 18.55B | 16.98B | 19.98B | 22B | 24.24B | |||||
Net Income to Common Incl Extra Items | 18.55B | 16.98B | 19.98B | 22B | 24.24B | |||||
Net Income to Common Excl. Extra Items | 18.55B | 16.98B | 19.98B | 22B | 24.24B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 101.38 | 92.8 | 109.16 | 120.23 | 132.48 | |||||
Basic EPS - Continuing Operations | 101.38 | 92.8 | 109.16 | 120.23 | 132.48 | |||||
Basic Weighted Average Shares Outstanding | 183M | 183M | 183M | 183M | 183M | |||||
Net EPS - Diluted | 101.38 | 92.8 | 109.16 | 120.23 | 132.48 | |||||
Diluted EPS - Continuing Operations | 101.38 | 92.8 | 109.16 | 120.23 | 132.48 | |||||
Diluted Weighted Average Shares Outstanding | 183M | 183M | 183M | 183M | 183M | |||||
Normalized Basic EPS | 92.71 | 82.5 | 101.85 | 110.48 | 117.46 | |||||
Normalized Diluted EPS | 92.71 | 82.5 | 101.85 | 110.48 | 117.46 | |||||
Dividend Per Share | 32.5 | 26.25 | 33 | 37.5 | 42.5 | |||||
Payout Ratio | 29.59 | 30.98 | 26.34 | 29.53 | 30.19 | |||||
Supplemental Items | ||||||||||
EBITDA | 34.06B | 31.16B | 35.69B | 45.76B | 47.36B | |||||
EBITA | 28.85B | 25.02B | 30.16B | 33.14B | 35.31B | |||||
EBIT | 28.39B | 24.55B | 29.7B | 33.14B | 35.31B | |||||
Effective Tax Rate - (Ratio) | 32.75 | 30.47 | 31.54 | 29.24 | 29.01 | |||||
Normalized Net Income | 16.97B | 15.1B | 18.64B | 20.22B | 21.49B | |||||
Non-Cash Pension Expense | 1.35B | 526M | -367M | 1.48B | 1.55B | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 3.67B | 3.79B | 4.08B | 3.83B | 4.18B | |||||
Selling and Marketing Expenses | 3.67B | 3.79B | 4.08B | 3.83B | 4.18B | |||||
Research And Development Expense From Footnotes | 2B | 1.69B | 1.94B | 2.32B | 2.4B |